Last reviewed · How we verify

NCT07157150: CARDIO-TECH SS

The Effects of Rule Modifications in 3v3 and 4v4 Small-Sided Games on Cardiovascular and Technical Performance in Elite Football Players

Completed NA Last updated 5 September 2025
What this trial tests

NA trial testing Free Play SSG in Exercise Training in 24 participants. Completed in 1 June 2023.

Timeline
1 August 2020
Primary endpoint
1 June 2022
1 June 2023

Quick facts

Lead sponsorHamza Kucuk
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment24
Start date1 August 2020
Primary completion1 June 2022
Estimated completion1 June 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hamza Kucuk

Who can join

Adults 18 to 30, male only, with Exercise Training or Exercise Physiology. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study explores how different small-sided football games affect players' heart and technical skills. We will compare two ways of playing: "Free Play," where players act freely, and "Controlled Pass," where passing rules are used. Elite football players will participate in both types of games on small fields (3 vs 3 and 4 vs 4). We will measure heart responses (like heart rate) and how often players touch the ball. The goal is to help coaches choose the best game format to improve fitness and technical ability in training.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Exercise Training

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07157150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing